Effect of retinoids and carotenoids on prostaglandin formation by oral squamous carcinoma cells.
Several studies have correlated the excessive production of prostaglandins (PGs) with tumor promotion and the suppression of the immune response. Inhibition of PGs by pharmacological agents has been demonstrated to enhance immunocompetence, and to suppress growth of tumors in animals and humans. In this study we examined the effect of retinol (I), all-trans-retinoic acid (II), N-(4-Hydroxyphenyl) retinamide (N-4-HPR) (III), canthaxanthin (CTX) (IV), and beta-carotene (beta-CT) (V) on the bioconversion of 14C-arachidonic acid (AA) to PGE2 by squamous carcinoma cells of the tongue, SCC-25. Agents (I), (II), (III), (IV) inhibited while (V) stimulated PGE2 formation in a dose related manner. N-4-HPR was the most potent inhibitor of PGE2 synthesis. The data suggest that certain retinoids and carotenoids have the potential of inhibition of PG synthesis by oral squamous carcinoma cells. Inhibitory effects such as those described here and antioxidant properties might in part contribute to the antiinflammatory and anticarcinogenic activity of retinoids in vivo.
ElAttar
T M
TM
Laboratory of Hormone Research, University of Missouri-Kansas City School of Dentistry, Missouri 64108.
Lin
H S
HS
D016644:Canthaxanthin; D002294:Carcinoma, Squamous Cell / Q000378:metabolism*; D002338:Carotenoids / Q000031:analogs & derivatives / Q000494:pharmacology*; D002855:Chromatography, Thin Layer; D017313:Fenretinide; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D011453:Prostaglandins / Q000096:biosynthesis*; D012176:Retinoids / Q000494:pharmacology*; D014062:Tongue Neoplasms / Q000378:metabolism*; D014212:Tretinoin / Q000031:analogs & derivatives / Q000494:pharmacology; D014407:Tumor Cells, Cultured; D014801:Vitamin A / Q000494:pharmacology; D019207:beta Carotene
D011453:Prostaglandins; D012176:Retinoids; D019207:beta Carotene; D014801:Vitamin A; D017313:Fenretinide; D002338:Carotenoids; D016644:Canthaxanthin; D014212:Tretinoin; D007213:Indomethacin